Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 May 22;85:104576. doi: 10.1016/j.jddst.2023.104576

Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]

Sally Abou Taleb a, Yassmin Moatasim b, Mohamed GabAllah b, Marwa Hasanein Asfour a,
PMCID: PMC10202194  PMID: 37303498

The original authors regret that the author names of:

Kamel H. Shaker (Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Institute, National Research Center, El-Behoos st, Dokki, Giza, 12622, Egypt) and Salha M Aljubiri (Department of Chemistry, College of Science, University of Bisha, Bisha 61922, P.O. Box 551, Saudi Arabia) were not added in the author list. Thus, the original authors would like to add their names and affiliations to the author list. The original authors would like to clarify that the quercitrin compound was not a gift from the two new authors. The authors would like to apologise for any inconvenience caused.


Articles from Journal of Drug Delivery Science and Technology are provided here courtesy of Elsevier

RESOURCES